The invention relates to the detection and quantification of cyclopropylindole based synthetic cannabinoids UR-144 and XLR-11 by providing antobodies based on novel immunogens.
These antobodies can be incorporated into methods and kits for the detection of UR-144, XLR-11 and metabolites or derivatives thereof.
                            本发明涉及通过提供基于新型免疫原的
抗体来检测和定量环丙基
吲哚类合成
大麻素 UR-144 和 XLR-11。
这些
抗体可纳入检测 UR-144、XLR-11 及其代谢物或衍
生物的方法和试剂盒中。